Sichuan Jinjiang Electronic Science and Technology

Established in 1991, JJET is located in the Wuhou National Science Park within Chengdu’s High-Tech Industry Development Zone. The company occupies an area of 22,805 sq. meters for office, R&D, and production facilities. For decades, JJET has been focused on the R&D, production, and marketing of cardiac electrophysiology devices, including the 3Ding Cardiac Mapping System, Electrophysiology Recording System, Cardiac RF Ablation Generator, Cool-pump Irrigation Pump, Electrophysiology Catheters, Ablation Catheters, Neural RF Generator etc. With sales networks across China, JJET has over 1,000 institutional users. It constantly strives to pursue scientific and technological innovations. At present, the proportion of R&D personnel is more than 23% of total staff, having obtained 71 authorized patents and 74 patents in application process. As a pioneer in Chinese electrophysiology industry, we are committed to providing comprehensive solutions to cure arrhythmia.

As a witness of the development of China’s interventional cardiology since its establishment in 1991, JJET has been focusing on the R&D, manufacturing, sales and service of high-end medical equipment. By virtue of our own technical capability and capacity, we have succeeded in developing series of advanced EP interventional equipment with proprietary intellectual property, providing our customers with safe and efficient service. Milestones of JJET’s development in the past two decades are listed below:

1991, we developed the first cardiac RF generator in China;

1996, we developed the first full-digital EP management system with 16 leads in China;

2003, we developed the first hemodynamic monitoring system with pressure guide wire measurement and analysis functions in China;

2004, we signed agreement and launched cooperation with C.R. Bard Inc., a globally renowned incorporation in cardiac EP field;

2004, we formally settled in Wuhou National Science Park in Chengdu High-Tech Industry Development Zone;

2007, our HL-100G Cardiac RF Generator entered the international market, making us the first Chinese supplier to compete in the EP Lab of Western countries with similar products;

2009, we developed the first 3D cardiac mapping and localization system;

2009, HL-100G Cardiac RF Generator was approved by US Food and Drug Administration (FDA);

2011, we succeeded in acquiring Cardima Inc., a US EP consumable manufacturer;

2013, 3D Cardiac Mapping System was approved by China Food and Drug Administration(CFDA);

2015, Electrophysiology Recording System and Cardiac RF Ablation Generator got CE Marking;

We'll highlight our development in the EP field as we always did to proactively keep up with the leading edge of the medical equipment industry; meanwhile we are seeking for more partners worldwide to extend our business to other medical devices to fulfill our mission of "cherishing life with technology".